Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Atherosclerosis Prevention in Air Pollution
NCT04762472Phase 4Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in atherosclerosis, sponsored by The Chinese University of Hong Kong. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT04762472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762472.